GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Price-to-Free-Cash-Flow

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Price-to-Free-Cash-Flow : 10.00 (As of Apr. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Price-to-Free-Cash-Flow?

As of today (2024-04-27), IntelliPharmaCeutics International's share price is $0.06. IntelliPharmaCeutics International's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Aug. 2023 was $0.01. Hence, IntelliPharmaCeutics International's Price-to-Free-Cash-Flow Ratio for today is 10.00.

The historical rank and industry rank for IntelliPharmaCeutics International's Price-to-Free-Cash-Flow or its related term are showing as below:

IPCIF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.42   Med: 12.86   Max: 110
Current: 11.43

During the past 13 years, IntelliPharmaCeutics International's highest Price-to-Free-Cash-Flow Ratio was 110.00. The lowest was 5.42. And the median was 12.86.

IPCIF's Price-to-Free-Cash-Flow is ranked better than
82.71% of 214 companies
in the Biotechnology industry
Industry Median: 30.52 vs IPCIF: 11.43

IntelliPharmaCeutics International's Free Cash Flow per Share for the three months ended in Aug. 2023 was $0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 48.50% per year.

During the past 13 years, IntelliPharmaCeutics International's highest 3-Year average Free Cash Flow per Share Growth Rate was 68.90% per year. The lowest was -38.90% per year. And the median was 9.30% per year.


IntelliPharmaCeutics International Price-to-Free-Cash-Flow Historical Data

The historical data trend for IntelliPharmaCeutics International's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Price-to-Free-Cash-Flow Chart

IntelliPharmaCeutics International Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 26.67 - -

IntelliPharmaCeutics International Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 13.57

Competitive Comparison of IntelliPharmaCeutics International's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, IntelliPharmaCeutics International's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntelliPharmaCeutics International's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Price-to-Free-Cash-Flow falls into.



IntelliPharmaCeutics International Price-to-Free-Cash-Flow Calculation

IntelliPharmaCeutics International's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.06/0.006
=10.00

IntelliPharmaCeutics International's Share Price of today is $0.06.
IntelliPharmaCeutics International's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

IntelliPharmaCeutics International  (OTCPK:IPCIF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


IntelliPharmaCeutics International Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Headlines